CoChat

Using real‐world data to evaluate the association of incretin‐based therapies with risk of acute pancreatitis: a meta‐analysis of 1 324 515 patients from observational studies

Wang, T., Wang, F., Gou, Z., Tang, H., Li, C., Shi, L., Zhai, S. · 2015 · Diabetes, Obesity and Metabolism
Cited by 62

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Aim: To investigate the real‐world incidence of acute pancreatitis ( AP ) associated with incretin‐based therapy ( IBT ). Methods: We carried out a systematic review and meta‐analysis of observational studies using Medline, PubMed , Embase, the Cochrane Database, ClinicalTrials.gov and conference proceedings. We included: those studies in which AP was a pre‐defined clinical outcome; longitudinal studies (case–control, cohort); studies that adjusted for confounders; studies that reported on a population exposed to IBT ; studies in which non‐ IBT users or past users (who received IBTs >90 days before the index date) were used as the control group; studies that reported risk estimates [relative risks, odds ratios ( ORs ) or hazard ratios] with 95% confidence intervals ( CIs ) for AP event with IBT use, or that reported sufficient data to estimate these; and publications in the English language. Data were extracted by two independent investigators, and a consensus was reached with involvement of a third. Study‐specific ORs from seven cohort studies and two case–control studies were meta‐analysed using random‐effects models. Associations were tested in subgroups representing different patient characteristics and study quality. Results: A total of nine studies that included 1 324 515 patients and 5195 cases of AP were included in our meta‐analysis. The summary estimate of OR for an association between IBT and AP was 1.03 (95% CI 0.87–1.20). Conclusions: The present meta‐analysis of real‐world data does not suggest that IBT is associated with AP . Although we should continue to remain vigilant, IBTs should be regarded as reasonable options to consider adding to the regimen of a patient with type 2 diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dom.12386

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 62

Metadata

Authors
Wang, T., Wang, F., Gou, Z., Tang, H., Li, C., Shi, L., & Zhai, S.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2014-10-06
Volume
17
Issue
1
Pages
32-41
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2058350670
Cited by
62
References
14
FWCI
4.48
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.